Rheumnow Podcast ACR24 - Day2b
Nov 18, 2024
Joining the discussion are Peter Nash, an expert on JAK inhibitors, Mrinalini Dey, a rheumatologist focusing on methotrexate side effects, and Chris Wincup, who dives into neuropsychiatric lupus. They reveal fascinating insights into JAK inhibitors, their safety, and the importance of vaccinations. Dey shifts perspectives on methotrexate side effects, while she and Wincup emphasize recognizing neuropsychiatric symptoms in lupus, advocating for improved communication and awareness in patient care.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
Innovations in Rheumatology: JAK Inhibitors and Palliative Care
02:23 • 22min
Advancements in PMR Management
24:39 • 5min
Innovative Approaches in Rheumatoid Arthritis Management
29:22 • 3min
Treatment Strategies in Psoriatic Arthritis
32:49 • 6min
Effectiveness of Upadacitinib in Treating Giant Cell Arteritis: Subgroup Insights
38:51 • 5min
Understanding Neuropsychiatric Lupus
43:42 • 9min